While I believe you're right, it won't stop in 2020, in fact that may be when the company's greatest growth occurs. Why? Because beginning about 2020 FDA trials for OWCP's products may be concluding and with actual drug approvals, sales and the revenue the company receives from drug sales could absolutely explode.
Certainly, I believe we could gain drug approvals in some countries before 2020, and hopefully we'll initiate some product sales by mid 2018 as cosmetics and cannabis based nutraceuticals, the massive growth will come with FDA drug approvals as FDA approval will lead to approval practically everywhere in the world.
Of course their is a lot of other positive news that will come before then, and much will involve how clinical trials will be funded. This might largely depend on partnerships, and depending on the size of these partnerships will determine how rapidly drug trials can be run.
If OWCP partners with a big Pharma that has practically unlimited funds, clinical trials can be conducted at virtually hundreds of clinical sites, so large trials can recruit all required participants very rapidly. On the other hand, if OWCP partners with other small companies, trials might be limited to a few sites in Israel, and hopefully a couple in the U.S., but the trial will take far longer, but can be funded essentially by product sales rather than a massive infusion of cash which could come in a partnership with a big Pharma or major Biotech. While terms in partnerships with smaller companies would probably be better, the company might actually grow faster with the lesser terms big Pharma may offer because of the accelerated time to approval of their products. In the long run, either course should still lead to tremendous success.
If I'm right, a decade from now OWCP will be trading well into triple digits, and perhaps will have split.
Gary
News 
Market Data 
Discover 
